At the end of the study, the treated group reported a significant improvement in asthma and rhinitis symptoms and lower serum levels of eosinophil cationic protein (ECP), IL-13, PRL, and adrenocorticotropic hormone (ACTH). The gene discussed is POMC; the disease is asthma.